Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-22

Clinical Trial Update: Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effect of Cinnamomum cassia on IGF-1 and metabolic control in metformin-treated type 2 diabetes patients with inadequate glycemic co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cinnamomum cassia (Cinnamomum cassia)
  • metformin (metformin)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED